OPERATING SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2023

OPERATING SEGMENTS

Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

	December 31, 2022
	2022 Reported					Fixed	2022 Reported
	Valued at 2022				Currency		Valued at 2023
(millions)	Management Rates		Other		Rate Change		Management Rates
Net Sales
Global Industrial		$6,944.0		$-		($207.7)		$6,736.3
Global Institutional & Specialty		4,480.0		10.2		(75.9)		4,414.3
Global Healthcare & Life Sciences		1,570.0		-		(64.2)		1,505.8
Other		1,355.0		(10.2)		(31.5)		1,313.3
Corporate		124.1		-		(0.4)		123.7
Subtotal at fixed currency rates		14,473.1		-		(379.7)		14,093.4
Effect of foreign currency translation		(285.3)				379.7		94.4
Consolidated reported GAAP net sales		$14,187.8		$-		$-		$14,187.8
Operating Income
Global Industrial		$977.0		$0.8		($42.0)		$935.8
Global Institutional & Specialty		634.5		(1.6)		(11.2)		621.7
Global Healthcare & Life Sciences		205.0		(1.8)		(9.9)		193.3
Other		212.8		2.6		(5.5)		209.9
Corporate		(416.7)		-		2.3		(414.4)
Subtotal at fixed currency rates		1,612.6		-		(66.3)		1,546.3
Effect of foreign currency translation		(50.1)				66.3		16.2
Consolidated reported GAAP operating income		$1,562.5		$-		$-		$1,562.5

Schedule of financial information for each of the entity's reportable segments

	First Quarter Ended
	March 31
(millions)	2023		2022
Net Sales
Global Industrial		$1,699.3		$1,511.4
Global Institutional & Specialty		1,126.6		991.3
Global Healthcare & Life Sciences		378.6		348.2
Other		329.3		286.8
Corporate		23.6		34.6
Subtotal at fixed currency rates		3,557.4		3,172.3
Effect of foreign currency translation		14.2		94.4
Consolidated reported GAAP net sales		$3,571.6		$3,266.7
Operating Income
Global Industrial		$215.6		$179.9
Global Institutional & Specialty		125.7		108.6
Global Healthcare & Life Sciences		35.0		41.9
Other		50.1		37.1
Corporate		(77.4)		(129.0)
Subtotal at fixed currency rates		349.0		238.5
Effect of foreign currency translation		2.6		16.0
Consolidated reported GAAP operating income		$351.6		$254.5